Assessment of Complement Activation by Nanoparticles: Development of a SPR Based Method and Comparison with Current High Throughput Methods
暂无分享,去创建一个
[1] Christine Vauthier,et al. Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona. , 2017, International journal of pharmaceutics.
[2] S. Lesieur,et al. New nanoparticles obtained by co-assembly of amphiphilic cyclodextrins and nonlamellar single-chain lipids: Preparation and characterization. , 2017, International journal of pharmaceutics.
[3] C. Vauthier,et al. Serial multiple crossed immunoelectrophoresis at a microscale: A stamp‐sized 2D immunoanalysis of protein C3 activation caused by nanoparticles , 2016, Electrophoresis.
[4] Julien Breault-Turcot. Développement d’outils analytiques pour la détection de biomolécules directement dans des fluides sanguins , 2016 .
[5] B. Liedberg,et al. Component-Specific Analysis of Plasma Protein Corona Formation on Gold Nanoparticles Using Multiplexed Surface Plasmon Resonance. , 2016, Small.
[6] E. Lavik,et al. Materials design at the interface of nanoparticles and innate immunity. , 2016, Journal of materials chemistry. B.
[7] A. Kim,et al. Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[8] Arunas Ramanavicius,et al. Development of a reusable protein G based SPR immunosensor for direct human growth hormone detection in real samples , 2015 .
[9] V. Frémeaux-Bacchi,et al. Complement System Part I – Molecular Mechanisms of Activation and Regulation , 2015, Front. Immunol..
[10] Lubka T. Roumenina,et al. Complement System Part II: Role in Immunity , 2015, Front. Immunol..
[11] S M Moghimi,et al. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[12] Giulio Caracciolo,et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.
[13] S. Moghimi,et al. Complement sensing of nanoparticles and nanomedicines , 2012 .
[14] Andrew Emili,et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.
[15] M. Harboe,et al. Advances in assay of complement function and activation. , 2011, Advanced drug delivery reviews.
[16] Yusuke Arima,et al. Surface plasmon resonance in monitoring of complement activation on biomaterials. , 2011, Advanced drug delivery reviews.
[17] A. Drake,et al. A strategic and systematic approach for the determination of biosensor regeneration conditions. , 2011, Journal of immunological methods.
[18] Seokheun Choi,et al. Methods of reducing non-specific adsorption in microfluidic biosensors , 2010 .
[19] V. Thongboonkerd,et al. Specific adsorption of some complement activation proteins to polysulfone dialysis membranes during hemodialysis. , 2009, Kidney international.
[20] John D. Lambris,et al. Modulation of the anti-tumor immune response by complement , 2008, Nature Immunology.
[21] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[22] Bo Nilsson,et al. Complement analysis in the 21st century. , 2007, Molecular immunology.
[23] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[24] Jean-Francois Masson,et al. Reduction of nonspecific protein binding on surface plasmon resonance biosensors , 2006, Analytical and bioanalytical chemistry.
[25] S. Lesieur,et al. Characterization of Dextran−Poly(isobutylcyanoacrylate) Copolymers Obtained by Redox Radical and Anionic Emulsion Polymerization , 2006 .
[26] Janos Szebeni,et al. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.
[27] Hirata,et al. Study of complement activation on well-defined surfaces using surface plasmon resonance. , 2000, Colloids and surfaces. B, Biointerfaces.
[28] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[29] K. Andersson,et al. Exploring buffer space for molecular interactions , 1999, Journal of molecular recognition : JMR.
[30] R. Ponikvar,et al. Anaphylatoxins C3a and C5a Adsorption on Acrylonitrile Membrane of Hollow-fiber and Plate Dialyzer – an in Vivo Study , 1990, The International journal of artificial organs.
[31] P. Couvreur,et al. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties , 1979, The Journal of pharmacy and pharmacology.
[32] Robert B Sim,et al. Handbook of Immunological Properties of Engineered Nanomaterials Chapter 11 Complement Activation , 2012 .
[33] B. Zoltán. Hemocompatibility testing for nanomedicines and biologicals: predictive assays for complement mediated infusion reactions , 2012 .
[34] Bo Nilsson,et al. The role of complement in biomaterial-induced inflammation. , 2007, Molecular immunology.
[35] John D Lambris,et al. Exploring the complement interaction network using surface plasmon resonance. , 2007, Advances in experimental medicine and biology.
[36] B. Nilsson,et al. Complement analysis in the 21 st century , 2007 .
[37] D. Labarre,et al. Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum. , 1992, Biomaterials.